ADH6: Key Enzyme in Alcohol Metabolism and Disease (G130)

Target Name: ADH6

NCBI ID: G130

ADH6

ADH6: Key Enzyme in Alcohol Metabolism and Disease

Alcohol dehydrogenase 6 (ADH6), also known as isoform 1, is an enzyme involved in the metabolism of alcohol to toxic metabolites. It is a key enzyme in the liver that converts alcohol to ethyl acetoacetate, which is then metabolized to ethyl acetate esters and acetic acid, which are then excreted by the liver. ADH6 exists in the body of humans and other animals, but its activity may be affected by a variety of factors, such as the amount of drinking, frequency of drinking, drinking time, alcohol concentration in the body, etc.

In recent years, researchers have discovered that ADH6 plays an important role in certain diseases, such as liver disease, diabetes, obesity, neurodegenerative diseases, etc. In addition, ADH6 has also been found to be a potential drug target that can be used to treat a variety of diseases.

First, the role of ADH6 in liver disease has been extensively studied. The liver is the center of metabolism and detoxification in the human body and is also the main location of ADH6. In the liver, ADH6 is responsible for converting alcohol in drinking into ethyl acetoacetate and sending it to the tricarboxylic acid cycle for metabolism. In some liver diseases, such as cirrhosis, fatty liver, etc., the activity of ADH6 may be affected, leading to alcohol metabolism disorders and aggravating disease symptoms. Therefore, ADH6 has become a potential drug target.

Secondly, the role of ADH6 in diabetes has also received attention. Diabetes is a common metabolic disease primarily characterized by elevated blood sugar levels. Drinking alcohol is a significant cause of elevated blood sugar levels in people with diabetes. ADH6 may play an important role in the onset and development of diabetes. Research shows that the activity of ADH6 is affected by various factors, such as the amount of alcohol consumed, frequency of alcohol consumption, and alcohol concentration in the body. In addition, the activity of ADH6 may also be affected by factors such as the physical condition and lifestyle of diabetic patients. Therefore, ADH6 can be used as a potential drug target for the treatment of diabetes.

Third, the role of ADH6 in obesity and neurodegenerative diseases has also been studied. Obesity is a common chronic disease and is closely related to the activity of ADH6. Studies have shown that the activity of ADH6 is affected by the fat content in the body of obese patients. The higher the fat content, the lower the activity of ADH6. In addition, the activity of ADH6 may also be affected by neurodegenerative diseases, such as Parkinson's disease, Alzheimer's disease, etc. These diseases are related to the activity of ADH6, therefore, ADH6 can be used as a potential drug target.

Finally, the role of ADH6 in drug metabolism and drug response has also been studied. Many drugs require the participation of ADH6 during their metabolism and excretion in the human body. Research shows that the activity of ADH6 is affected by drugs, such as the pharmacokinetics and pharmacodynamics of drugs. In addition, the activity of ADH6 may also be affected by drinking alcohol. Drinking alcohol will reduce the activity of ADH6, increase the residence time of the drug in the body, and increase the toxicity of the drug. Therefore, ADH6 can be used as a potential drug target for the treatment of diseases related to drug metabolism and drug response.

To sum up, ADH6 is an enzyme that plays an important role in liver disease, diabetes, obesity, neurodegenerative diseases and other fields. In recent years, researchers have discovered that ADH6 also serves as a potential drug target that can be used to treat a variety of diseases. However, there are still many shortcomings in the current research on ADH6, and further research is needed to deeply explore the role of ADH6 in drug metabolism and disease treatment.

Protein Name: Alcohol Dehydrogenase 6 (class V)

The "ADH6 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about ADH6 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets